adalgisa condoluci
Division of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale
Switzerland
- Frontiers in Oncology
- Hematologic Malignancies
- Research Topics
- Biology and Treatment of High-Risk CLL
Biology and Treatment of High-Risk CLL
16k
Total downloads
64k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
70 Authors
anastasia chatzidimitriou
Institute of Applied Biosciences, Centre for Research and Technology Hellas
Greece
anna panovská
Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University
Czechia
anton w. langerak
Laboratory Medical Immunology, Department of Immunology, Erasmus MC
Netherlands
antonella nicolò
Institute of Immunology, Ulm University
Germany
arnon p. kater
Department of Hematology, Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam
Netherlands
catherine j. wu
Department of Medical Oncology, Dana-Farber Cancer Institute
United States
christos demosthenous
Hematology Department—Bone Marrow Transplantation (BMT) Unit, G. Papanicolaou Hospital
Greece
david donaldson
Haematology Department, Belfast Health and Social Care Trust
United Kingdom
davide rossi
Division of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale
Switzerland
eugen tausch
Division of Chronic Lymphocytic Leukemia (CLL), Department of Internal Medicine III, Ulm University
Germany
eva ondroušková
Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University
Czechia
...
Published in
Frontiers in Oncology
- Hematologic Malignancies
Impact
- 64kTopic views
- 45kArticle views
- 16kArticle downloads